SCHEMBL18617396

SCHEMBL18617396

Nc1cc(CN(N)c2ccccc2N)c(N)c(N)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18616509 0.82 MPO (0.39) —
SCHEMBL18616572 0.81 KMT2A (0.41) —
SCHEMBL18617402 0.81 MPO (0.33) —
SCHEMBL18617663 0.81 SMN1; SMN2 (0.33) —
SCHEMBL18617301 0.78 NPC1 (0.34) —
SCHEMBL18617434 0.74 MPO (0.40) —
SCHEMBL18616504 0.68 MPO (0.33) —
SCHEMBL4801307 0.68 AOC3 (0.48) —
SCHEMBL24773983 0.65 CYP3A4 (0.41) —
SCHEMBL18620550 0.63 NOS2 (0.42) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017040449-A1 TRIAZOLOPYRIDINE INHIBITORS OF MYELOPEROXIDASE BRISTOL-MYERS SQUIBB COMPANY (US) 2017-03-09 — — WO disclosed
Send feedback